Beyond IκBs:: alternative regulation of NF-κB activity

被引:228
作者
Neumann, Manfred [1 ]
Naumann, Michael [1 ]
机构
[1] Otto Von Guericke Univ, Fac Med, Inst Expt Internal Med, D-39120 Magdeburg, Germany
关键词
RelA phosphorylation; RelA acetylation; GR/NF-kappa B cross-talk; nucleolar sequestration; dimer exchange;
D O I
10.1096/fj.06-7615rev
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor nuclear factor-kappa B ( NF- kappa B) is a crucial regulator of many physiological and patho- physiological processes, including control of the adaptive and innate immune responses, inflammation, proliferation, tumorigenesis, and apoptosis. Thus, the tight regulation of NF- kappa B activity within a cell is extremely important. The central mechanism of NF- kappa B regulation is the signal- induced proteolytic degradation of a family of cytoplasmic inhibitors of NF- kappa B, the I kappa Bs. However, with the discovery of an I kappa B- independent noncanonical or '' alternative '' pathway of NF- kappa B activation, the importance of other regulatory mechanisms responsible for the fine- tuning of NF- kappa B became clear. Post- translational modification, especially phosphorylation, of the Rel proteins, of which dimeric NF- kappa B is composed, are such alternative regulatory mechanisms. The best analyzed example is RelA phosphorylation, which takes place at specific amino acids resulting in distinct functional changes of this gene regulatory protein. The interaction of NF- kappa B with other proteins such as glucocorticoid receptors is very important for the regulation of NF- kappa B activity. Recently, exciting new concepts of I kappa B- independent NF- kappa B control like dimer exchange and nucleolar sequestration of RelA have been described, indicating that many aspects of NF- kappa B control are waiting to be discovered. - Neumann, M., Naumann, M. Beyond I kappa Bs: alternative regulation of NF- kappa B activity.
引用
收藏
页码:2642 / 2654
页数:13
相关论文
共 98 条
[71]   Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA [J].
Ryo, A ;
Suizu, F ;
Yoshida, Y ;
Perrem, K ;
Liou, YC ;
Wulf, G ;
Rottapel, R ;
Yamaoka, S ;
Lu, KP .
MOLECULAR CELL, 2003, 12 (06) :1413-1426
[72]   Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor κB response [J].
Saccani, S ;
Marazzi, I ;
Beg, AA ;
Natoli, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01) :107-113
[73]   Modulation of NF-κB activity by exchange of dimers [J].
Saccani, S ;
Pantano, S ;
Natoli, G .
MOLECULAR CELL, 2003, 11 (06) :1563-1574
[74]   IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain [J].
Sakurai, H ;
Chiba, H ;
Miyoshi, H ;
Sugita, T ;
Toriumi, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30353-30356
[75]   Glycogen synthase kinase 3β-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor κB signaling [J].
Sanchez, JF ;
Sniderhan, LF ;
Williamson, AL ;
Fan, SS ;
Chakraborty-Sett, S ;
Maggirwar, SB .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (13) :4649-4662
[76]   NF-κB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity [J].
Sanchez-Valdepenas, Carmen ;
Martin, Angel G. ;
Ramakrishnan, Parameswaran ;
Wallach, David ;
Fresno, Manuel .
JOURNAL OF IMMUNOLOGY, 2006, 176 (08) :4666-4674
[77]   Phosphorylation of RelA/p65 on serine 536 defines an IκBα-independent NF-κB pathway [J].
Sasaki, CY ;
Barberi, TJ ;
Ghosh, P ;
Longo, DL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (41) :34538-34547
[78]   IKKβ phosphorylates p65 at S468 in transactivaton domain 2 [J].
Schwabe, RF ;
Sakurai, H .
FASEB JOURNAL, 2005, 19 (09) :1758-+
[79]   Mutations of tumor necrosis factor α-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability [J].
Starczynowski, DT ;
Reynolds, JG ;
Gilmore, TD .
ONCOGENE, 2005, 24 (49) :7355-7368
[80]  
STARCZYNOWSKI DT, 2006, IN PRESS ONCOGENE